Hydroxychloroquine to treat Coronavirus Patients: Are the Nevada Governor and President of France in the Pay of Big-Pharma?
By Dr. Paul Craig Roberts
Global Research, March 29, 2020

Url of this article:

This question is invited by news reports that they are preventing the use of the anti-malaria drugs chloroquine and hydroxychloroquine to treat coronavirus patients.  According to experts, the anti-malaria drugs are effective if used early enough in the infection.  But the drugs are cheap and there is no profit in them.  

As of Tuesday, New York hospitals have federal permission to give desperately ill patients a cocktail of hydroxychloroquine and azithromycin on a “compassionate care” basis.

Marseille professor seeking to cure Covid-19

According to the world’s leading expert, Didier Raoult (image on the right), it is too late to give the anti-malarial drugs in the latter stage of the infection, see this.   

Fauci says there is no substantive proof that the drugs are effective, but the Chinese and Didier Raoult, who is far more prominent than Fauci, say otherwise.


Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Dr. Paul Craig Roberts writes on his blog, PCR Institute for Political Economy, where this article was originally published. He is a frequent contributor to Global Research.

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article.